CLIPS BnC Inc.

CLIPS BnC Inc.

CLIPS BnC Inc. (the Company) is a full scope clinical contract research organization (CRO), and a biotechnology company focusing on the development of novel cell therapeutics and vaccines. As a CRO, the company provides comprehensive clinical development services, such as regulatory affairs consulting, medical writing, clinical trial management, and data management & statistics, to biopharmaceutical companies. The company is actively expanding its business overseas by establishing CLIPS BnC Thailand and a joint venture in China to address the needs of strategic partners in the APAC region. As a biotech, the company is developing a limbal stem cell therapy, which is about to enter the Phase 2 trial, and vaccines for infectious diseases with unmet medical needs, including respiratory syncytial virus (RSV) and methicillin resistant Staphylococcus aureus (MRSA).

Visit Website

Locations

  • APAC

Accreditations

Partners are trained on the functionality of the Coder application, process optimization, and scope of Coder services. This Accreditation teaches Partners to integrate the medical coding solution with EDC studies and administer Coder segments. Coder Accreditation is dependent on the successful completion of the Rave EDC accreditation.
Partners are trained on the functionality of the electronic data capture (EDC) and clinical data management (CDM) system, process optimization exercises and scope of Medidata Rave services. This Accreditation teaches the staff to perform end user training, user and site administration, study build, reporting, outputs and amendment manager.
Partners are trained on the functionality of the RTSM Application, process optimization, best practices using RTSM, and scope of RTSM services. This Accreditation teaches Partners to conduct randomization and clinical trial supply management services (RTSM). RTSM Accreditation is dependent on the successful completion of the Rave EDC Accreditation.